As the chief integration officer of the Southern California Permanente Medical Group, Kalvin Yu, MD, leads groundbreaking research on antibiotic stewardship programs, aimed at reducing the risk of antibiotic resistance among pathogens and stopping the rise of dangerous “superbugs.”